It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Most sequence variants identified hitherto in genome-wide association studies (GWAS) of atrial fibrillation are common, non-coding variants associated with risk through unknown mechanisms. We performed a meta-analysis of GWAS of atrial fibrillation among 29,502 cases and 767,760 controls from Iceland and the UK Biobank with follow-up in samples from Norway and the US, focusing on low-frequency coding and splice variants aiming to identify causal genes. We observe associations with one missense (OR = 1.20) and one splice-donor variant (OR = 1.50) in RPL3L, the first ribosomal gene implicated in atrial fibrillation to our knowledge. Analysis of 167 RNA samples from the right atrium reveals that the splice-donor variant in RPL3L results in exon skipping. We also observe an association with a missense variant in MYZAP (OR = 1.38), encoding a component of the intercalated discs of cardiomyocytes. Both discoveries emphasize the close relationship between the mechanical and electrical function of the heart.
Rosa Thorolfsdottir et al. report a genome-wide association study of atrial fibrillation in 29,502 cases and 767,760 controls from Iceland and the UK Biobank. They identify a significant association with coding variants in RPL3L, the first ribosomal gene implicated in atrial fibrillation, and MYZAP, an intercalated disc gene.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 deCODE genetics/Amgen, Inc., Reykjavik, Iceland; University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
2 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.14013.37)
3 University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan, Department of Human Genetics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
4 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.214458.e)
5 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.214458.e); University of Iceland, School of Engineering and Natural Sciences, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
6 University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); Landspitali University Hospital, Department of Cardiothoracic Surgery, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
7 Landspitali University Hospital, Department of Cardiothoracic Surgery, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
8 Akureyri Regional Hospital, Department of Medicine, Akureyri, Iceland (GRID:grid.410540.4)
9 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.410540.4); University Medical Center Utrecht, University of Utrecht, Department of Cardiology, Division Heart & Lungs, Utrecht, The Netherlands (GRID:grid.410540.4)
10 Norwegian University of Science and Technology, HUNT Research Centre, Department of Public Health and General Practice, Levanger, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); Norwegian University of Science and Technology, K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); St. Olav’s University Hospital, Department of Cardiology, Trondheim, Norway (GRID:grid.52522.32) (ISNI:0000 0004 0627 3560)
11 University Medical Center Utrecht, University of Utrecht, Department of Cardiology, Division Heart & Lungs, Utrecht, The Netherlands (GRID:grid.52522.32); Netherlands Heart Institute, Durrer Center for Cardiovascular Research, Utrecht, The Netherlands (GRID:grid.411737.7); University College London, Institute of Cardiovascular Science, Faculty of Population Health Sciences, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London, Farr Institute of Health Informatics Research and Institute of Health Informatics, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
12 Vanderbilt University Medical Center, Departments of Medicine, Pharmacology, and Biomedical Informatics, Nashville, USA (GRID:grid.412807.8) (ISNI:0000 0004 1936 9916)
13 University of Illinois at Chicago, Division of Cardiology, Department of Medicine, Chicago, USA (GRID:grid.185648.6) (ISNI:0000 0001 2175 0319)
14 University of Oslo, Center For Preventive Medicine, Oslo University Hospital and Medical Faculty, Oslo, Norway (GRID:grid.5510.1) (ISNI:0000 0004 1936 8921)
15 Brigham and Women’s Hospital and Harvard Medical School, TIMI Study Group, Division of Cardiovascular Medicine, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
16 University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan, Department of Human Genetics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370); University of Michigan, Department of Computational Medicine and Bioinformatics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
17 UiT The Arctic University of Norway, Department of Community Medicine, Tromsø, Norway (GRID:grid.10919.30) (ISNI:0000000122595234)
18 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.10919.30); Reykjavik University, Reykjavik, Iceland (GRID:grid.9580.4) (ISNI:0000 0004 0643 5232)
19 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.9580.4); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); Landspitali University Hospital, Department of immunology, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
20 Norwegian University of Science and Technology, HUNT Research Centre, Department of Public Health and General Practice, Levanger, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); Norwegian University of Science and Technology, K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393); Nord-Trøndelag Hospital Trust, Department of Medicine, Levanger Hospital, Levanger, Norway (GRID:grid.414625.0) (ISNI:0000 0004 0627 3093)
21 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.414625.0); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); Landspitali University Hospital, Department of Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
22 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.410540.4); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
23 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.14013.37); University of Iceland, School of Engineering and Natural Sciences, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
24 deCODE genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.14013.37); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)